sales@starshinechemical.com
CAS RN: 292135-78-5
Roflumilast N-Oxide
- Product code: ICTR0217
- Purity/Analytical Methods: >98.0%(HPLC)
Basic Information
| Appearance and Shape (20°C) | Solid |
|---|---|
| CAS RN | 292135-78-5 |
| MDL number | MFCD04112984 |
| Molecular weight | 419.21 |
| Molecular Formula | C17H14Cl2F2N2O4 |
| Product code | ICTR0217 |
| Purity/Analytical Methods | >98.0%(HPLC) |
| Reaxys-RN | 10715186 |
| Situations to avoid | Hygroscopic,Heat Sensitive |
| Store under inert gas | Store under inert gas |
Technical Specifications
Technical Specifications
| Appearance | White to Light yellow to Light orange powder to crystal |
|---|
Safety and Regulatory
GHS
| Pictograms |
|
|---|---|
| Hazard statement | H315 : Causes skin irritation H319 : Causes serious eye irritation. |
| Precautionary Statements | P264 : Wash skin thoroughly after handling P280 : Wear protective gloves/ eye protection/ face protection P337 + P313 : If eye irritation persists: Get medical advice/ attention P305 + P351 + P338 : IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing P302 + P352 : IF ON SKIN: Wash with plenty of soap and water P332 + P313 : If skin irritation occurs: Get medical advice/ attention P362 : Take off contaminated clothing and wash before reuse. |
| Signal word | Warning |
Product Category
Chemical structure
Life Science Biochemicals and Reagents Enzymes, Enzyme Inhibitors, Enzyme Substrates Enzyme Inhibitors [Biochemicals and Reagents] Enzyme Inhibitors [P to Q] Phosphodiesterase Inhibitors (3',5'-Cyclic Nucleotide) Enzyme Inhibitors by Enzyme Pharmaceutical Ingredients (for Research and Experimental Use) Anti-inflammatory Ingredients (for Research and Experimental Use) Non-Steroidal Anti-Inflammatories (NSAIDs) Pharmaceutical Development and Drug Discovery Research Pharmaceutical Ingredients (for Research and Experimental Use) Anti-inflammatory Ingredients (for Research and Experimental Use) Non-Steroidal Anti-Inflammatories (NSAIDs)